Status:
COMPLETED
A Clinical Study of Tobradex AF
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.
Eligibility Criteria
Inclusion
- Adult patients requiring cataract surgery
Exclusion
- Age related
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT00473070
Start Date
November 1 2006
Last Update
July 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pittsburgh
Pittsburgh, Pennsylvania, United States, 15122